chr15-33623951-T-A

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001036.6(RYR3):​c.2502T>A​(p.Ile834Ile) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00977 in 1,613,934 control chromosomes in the GnomAD database, including 1,122 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.048 ( 592 hom., cov: 33)
Exomes 𝑓: 0.0058 ( 530 hom. )

Consequence

RYR3
NM_001036.6 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -1.06

Publications

2 publications found
Variant links:
Genes affected
RYR3 (HGNC:10485): (ryanodine receptor 3) The protein encoded by this gene is a ryanodine receptor, which functions to release calcium from intracellular storage for use in many cellular processes. For example, the encoded protein is involved in skeletal muscle contraction by releasing calcium from the sarcoplasmic reticulum followed by depolarization of T-tubules. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2011]
RYR3 Gene-Disease associations (from GenCC):
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen, G2P
  • congenital myopathy
    Inheritance: AR Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.67).
BP6
Variant 15-33623951-T-A is Benign according to our data. Variant chr15-33623951-T-A is described in CliVar as Benign. Clinvar id is 461892.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr15-33623951-T-A is described in CliVar as Benign. Clinvar id is 461892.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr15-33623951-T-A is described in CliVar as Benign. Clinvar id is 461892.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr15-33623951-T-A is described in CliVar as Benign. Clinvar id is 461892.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr15-33623951-T-A is described in CliVar as Benign. Clinvar id is 461892.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr15-33623951-T-A is described in CliVar as Benign. Clinvar id is 461892.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr15-33623951-T-A is described in CliVar as Benign. Clinvar id is 461892.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.06 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.161 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RYR3NM_001036.6 linkc.2502T>A p.Ile834Ile synonymous_variant Exon 20 of 104 ENST00000634891.2 NP_001027.3 Q15413-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RYR3ENST00000634891.2 linkc.2502T>A p.Ile834Ile synonymous_variant Exon 20 of 104 1 NM_001036.6 ENSP00000489262.1 Q15413-1
RYR3ENST00000389232.9 linkc.2502T>A p.Ile834Ile synonymous_variant Exon 20 of 104 5 ENSP00000373884.5 A0A0X1KG73
RYR3ENST00000415757.7 linkc.2502T>A p.Ile834Ile synonymous_variant Exon 20 of 103 2 ENSP00000399610.3 Q15413-2
RYR3ENST00000634418.1 linkc.2502T>A p.Ile834Ile synonymous_variant Exon 20 of 102 5 ENSP00000489529.1 A0A0U1RRH1

Frequencies

GnomAD3 genomes
AF:
0.0482
AC:
7332
AN:
152140
Hom.:
588
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.164
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0169
Gnomad ASJ
AF:
0.0415
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.000809
Gnomad OTH
AF:
0.0339
GnomAD2 exomes
AF:
0.0142
AC:
3529
AN:
249072
AF XY:
0.0112
show subpopulations
Gnomad AFR exome
AF:
0.174
Gnomad AMR exome
AF:
0.00770
Gnomad ASJ exome
AF:
0.0417
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000984
Gnomad OTH exome
AF:
0.00529
GnomAD4 exome
AF:
0.00575
AC:
8409
AN:
1461676
Hom.:
530
Cov.:
32
AF XY:
0.00508
AC XY:
3696
AN XY:
727122
show subpopulations
African (AFR)
AF:
0.169
AC:
5664
AN:
33480
American (AMR)
AF:
0.00899
AC:
402
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0391
AC:
1023
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.000278
AC:
24
AN:
86258
European-Finnish (FIN)
AF:
0.0000562
AC:
3
AN:
53400
Middle Eastern (MID)
AF:
0.00347
AC:
20
AN:
5768
European-Non Finnish (NFE)
AF:
0.000451
AC:
501
AN:
1111840
Other (OTH)
AF:
0.0128
AC:
772
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
411
822
1232
1643
2054
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
188
376
564
752
940
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0483
AC:
7357
AN:
152258
Hom.:
592
Cov.:
33
AF XY:
0.0450
AC XY:
3347
AN XY:
74454
show subpopulations
African (AFR)
AF:
0.164
AC:
6822
AN:
41508
American (AMR)
AF:
0.0169
AC:
259
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.0415
AC:
144
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.000809
AC:
55
AN:
68018
Other (OTH)
AF:
0.0336
AC:
71
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
298
596
895
1193
1491
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
70
140
210
280
350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0193
Hom.:
47
Bravo
AF:
0.0550
Asia WGS
AF:
0.00751
AC:
26
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Epileptic encephalopathy Benign:1
Jan 06, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.67
CADD
Benign
0.99
DANN
Benign
0.64
PhyloP100
-1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2229118; hg19: chr15-33916152; COSMIC: COSV66802408; COSMIC: COSV66802408; API